TARDBP and proteostasis deficiencies: With this in mind, therapeutic strategies for TDP-43 proteinopathies should aim to (1) restore TDP-43 nuclear function, (2) remove cytoplasmic TDP-43 aggregates, or (3) prevent (prion-like) propagation of TDP-43 pathology; and ideally exert a combination of these effects.